The Board of Director of the Company has recommended a dividend of Rs. 0.50 paisa per Equity Share
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Titan Biotech Limited reported strong FY2026 results with total income rising 32% to Rs 2,116 crore from Rs 1,604 crore in FY2025. Net profit jumped 50% to Rs 274.47 lakh from Rs 182.71 lakh. The Board has recommended a dividend of Rs 0.50 per equity share for FY2026, subject to shareholder approval at the ensuing AGM. Additionally, the company completed a stock split effective February 20, 2026, reducing face value from Rs 10 to Rs 2 per share in a 1:5 ratio, increasing paid-up shares from 82.64 lakh to 4.13 crore shares. EPS improved from Rs 4.42 to Rs 6.64 on standalone basis.
The 50% jump in net profit and improved EPS indicate strong operational performance. The stock split enhances liquidity and accessibility for smaller investors. The modest dividend of Rs 0.50 reflects conservative payout despite improved profitability, which may indicate retained capital for growth opportunities.